Structural comparison of a 15 residue peptide from the V3 loop of HIV-1(IIIb) and an O-glycosylated analogue

被引:30
作者
Huang, XL
Smith, MC
Berzofsky, JA
Barchi, JJ
机构
[1] NCI,MED CHEM LAB,DIV BASIC SCI,NIH,BETHESDA,MD 20892
[2] NCI,MOL IMMUNOGENET & VACCINE RES SECT,DIV BASIC SCI,NIH,BETHESDA,MD 20892
基金
美国国家卫生研究院;
关键词
NMR; V3; loop; glycopeptide; CTL;
D O I
10.1016/0014-5793(96)00912-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As part of a program to study the effect of glycosylation an the three-dimensional structures of HIV-1(IIIB) V3 peptide constructs, we have examined the solution structures of a 15 residue peptide (RIQRGPGRAFVTIGK, P18(IIIB)), originally mapped as an epitope recognized by CD8(+) D-d class I MHC-restricted murine cytotoxic T-lymphocytes (CTL), and an analogue (P18(IIIB)-g), O-glycosylated with an alpha-galactosamine on Thr-12, using NMR, circular dichroism and molecular modeling methods, Our studies show Chat the peptides sample mainly random conformations in aqueous solution near 25 degrees C and become more ordered by the addition of trifluoroethanol, Upon decreasing the temperature to 5 degrees C, a reverse turn is famed around the immunodominant tip (G(5)-R(8)). Glycosylation on T-12 'tightens' the turn slightly as suggested by NOE and CD analysis, Ln addition, the sugar has a defined conformation with respect to the peptide backbone and influences the local peptide conformation, These data suggest that simple glycosylation mag. influence the conformational equilibrium of a V3 peptide which contains a domain critical for antibody recognition and virus neutralization, We also show that the ability of cytotoxic T-lymphocytes (CTL) to lyse tumor cells presenting P18(IIIB) was completely abrogated by threonine glycosylation.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 44 条
[1]   Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy [J].
AlexanderMiller, MA ;
Leggatt, GR ;
Berzofsky, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4102-4107
[2]   MLEV-17-BASED TWO-DIMENSIONAL HOMONUCLEAR MAGNETIZATION TRANSFER SPECTROSCOPY [J].
BAX, A ;
DAVIS, DG .
JOURNAL OF MAGNETIC RESONANCE, 1985, 65 (02) :355-360
[3]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN IS MODIFIED BY O-LINKED OLIGOSACCHARIDES [J].
BERNSTEIN, HB ;
TUCKER, SP ;
HUNTER, E ;
SCHUTZBACH, JS ;
COMPANS, RW .
JOURNAL OF VIROLOGY, 1994, 68 (01) :463-468
[4]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[5]  
BRUENGER AT, 1993, X PLOR V 3 1 SYSTEM
[6]   SOLUTION CONFORMATIONAL PREFERENCES OF IMMUNOGENIC PEPTIDES DERIVED FROM THE PRINCIPAL NEUTRALIZING DETERMINANT OF THE HIV-1 ENVELOPE GLYCOPROTEIN GP120 [J].
CHANDRASEKHAR, K ;
PROFY, AT ;
DYSON, HJ .
BIOCHEMISTRY, 1991, 30 (38) :9187-9194
[7]   ATTENUATION OF HIV-1 INFECTIVITY BY AN INHIBITOR OF OLIGOSACCHARIDE PROCESSING [J].
DEDERA, D ;
VANDERHEYDEN, N ;
RATNER, L .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (06) :785-794
[8]   NMR-DERIVED SOLUTION CONFORMATIONS OF A HYBRID SYNTHETIC PEPTIDE-CONTAINING MULTIPLE EPITOPES OF ENVELOPE PROTEIN GP120 FROM THE RF STRAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS [J].
DELORIMIER, R ;
MOODY, MA ;
HAYNES, BF ;
SPICER, LD .
BIOCHEMISTRY, 1994, 33 (08) :2055-2062
[9]   HUMAN TRIALS OF EXPERIMENTAL AIDS VACCINES [J].
FAST, PE ;
WALKER, MC .
AIDS, 1993, 7 :S147-S159
[10]  
FEIZI T, 1990, Glycobiology, V1, P17, DOI 10.1093/glycob/1.1.17